WallStSmart

Orthopediatrics Corp (KIDS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Orthopediatrics Corp stock (KIDS) is currently trading at $16.23. Orthopediatrics Corp PS ratio (Price-to-Sales) is 1.77. Analyst consensus price target for KIDS is $24.89. WallStSmart rates KIDS as Sell.

  • KIDS PE ratio analysis and historical PE chart
  • KIDS PS ratio (Price-to-Sales) history and trend
  • KIDS intrinsic value — DCF, Graham Number, EPV models
  • KIDS stock price prediction 2025 2026 2027 2028 2029 2030
  • KIDS fair value vs current price
  • KIDS insider transactions and insider buying
  • Is KIDS undervalued or overvalued?
  • Orthopediatrics Corp financial analysis — revenue, earnings, cash flow
  • KIDS Piotroski F-Score and Altman Z-Score
  • KIDS analyst price target and Smart Rating
KIDS

Orthopediatrics Corp

NASDAQHEALTHCARE
$16.23
$0.32 (2.01%)
52W$15.28
$26.40
Target$24.89+53.4%

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

Orthopediatrics Corp (KIDS) · 8 metrics scored

Smart Score

36
out of 100
Grade: F
Hold
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/sales, price/book, institutional own.. Concerns around return on equity and operating margin. Mixed signals suggest waiting for clearer direction before acting.

Orthopediatrics Corp (KIDS) Key Strengths (3)

Avg Score: 8.0/10
Price/SalesValuation
1.778/10

Paying $1.77 for every $1 of annual revenue

Price/BookValuation
1.218/10

Trading at 1.21x book value, attractively priced

Institutional Own.Quality
67.61%8/10

67.61% held by institutions, strong professional interest

Supporting Valuation Data

Price/Sales (TTM)
1.767
Undervalued
EV/Revenue
1.934
Undervalued
KIDS Target Price
$24.89
41% Upside

Orthopediatrics Corp (KIDS) Areas to Watch (5)

Avg Score: 2.2/10
Return on EquityProfitability
-11.30%0/10

Company is destroying shareholder value

Operating MarginProfitability
-8.94%0/10

Losing money on operations

Profit MarginProfitability
-16.80%0/10

Company is losing money with a negative profit margin

Market CapQuality
$418M5/10

Small-cap company with higher risk but more growth potential

Revenue GrowthGrowth
17.00%6/10

Solid revenue growth at 17.00% per year

Orthopediatrics Corp (KIDS) Detailed Analysis Report

Overall Assessment

This company scores 36/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 3 register as strengths (avg 8.0/10) while 5 fall into concern territory (avg 2.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Sales, Price/Book, Institutional Own.. Valuation metrics including Price/Sales (1.77), Price/Book (1.21) suggest the stock is attractively priced.

The Bear Case

The primary concerns are Return on Equity, Operating Margin, Profit Margin. Growth concerns include Revenue Growth at 17.00%, which may limit upside. Profitability pressure is visible in Return on Equity at -11.30%, Operating Margin at -8.94%, Profit Margin at -16.80%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -11.30% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 17.00% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

KIDS Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

KIDS's Price-to-Sales ratio of 1.77x trades at a deep discount to its historical average of 11.01x (0th percentile). The current valuation is 93% below its historical high of 25.11x set in Oct 2021, and 0% above its historical low of 1.77x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~3.0x as trailing revenue scaled faster than the stock price.

Compare KIDS with Competitors

Top MEDICAL DEVICES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Orthopediatrics Corp (KIDS) · HEALTHCAREMEDICAL DEVICES

The Big Picture

Orthopediatrics Corp is a strong growth company balancing expansion with improving profitability. Revenue reached 236M with 17% growth year-over-year. The company is currently unprofitable, posting a -16.8% profit margin.

Key Findings

Cash Flow Positive

Generating 10M in free cash flow and 10M in operating cash flow. Earnings are translating into actual cash generation.

Operating at a Loss

The company is unprofitable with a -16.8% profit margin. The path to breakeven will be the key catalyst.

What to Watch Next

Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Orthopediatrics Corp.

Bottom Line

Orthopediatrics Corp offers an attractive blend of growth (17% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions(10 last 3 months)

Total Buys
4
Total Sells
6
Dec 29, 2025(1 transaction)
BAILEY, DAVID R
Director, President and CEO
Sell
Shares
-1,600

Data sourced from SEC Form 4 filings

Last updated: 2:28:47 PM

About Orthopediatrics Corp(KIDS)

Exchange

NASDAQ

Sector

HEALTHCARE

Industry

MEDICAL DEVICES

Country

USA

OrthoPediatrics Corp. The company is headquartered in Warsaw, Indiana.